Alliance for Clinical Trials in Oncology Operations Center

肿瘤学临床试验联盟运营中心

• 批准号: 9906858
• 负责人: Monica M Bertagnolli
• 金额: $ 922.32万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9906858
• 关键词: Address; Adolescent and Young Adult; Adult; Behavior; Biological; Breast; Cancer Control; Cancer Patient; Characteristics; Clinical; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Collaborations; Communities; Community Clinical Oncology Program; Consensus; DNA; Data; Data Analyses; Data Collection; Discipline; Disease; Disease Resistance; Drug Combinations; Elderly; Electronic Health Record; Enrollment; Evaluation; Funding; Genitourinary system; Hematologic Neoplasms; Infrastructure; Lead; Leadership; Malignant Neoplasms; Medidata; Methods; Mission; Molecular; Molecular Analysis; National Clinical Trials Network; Neuraxis; New Agents; Oncology; Pathogenesis; Patient-Focused Outcomes; Patients; Prevention strategy; Prevention trial; Principal Investigator; Process; Recording of previous events; Regimen; Reporting; Research; Research Design; Research Personnel; Resistance; Resources; Role; Scientist; Special Populations Research; Testing; Translational Research; Underrepresented Minority; Validation; Variant; Vision; Work; base; cancer clinical trial; cancer prevention; cancer therapy; clinical practice; community setting; control trial; data sharing; design; effective therapy; experience; gastrointestinal; improved; innovation; member; multidisciplinary; multimodality; novel strategies; operation; patient engagement; prevent; programs; prospective; rare cancer; respiratory; response; therapy resistant; treatment trial; tumor

PROJECT SUMMARY The Alliance is an experienced multi-institutional cancer clinical trials group that has been reorganized in response to the IOM consensus report and NCI directives for cooperative group reorganization. Alliance provides a comprehensive and highly efficient clinical trials infrastructure, access to experienced collaborators across all disciplines of oncology clinical trials research, and a diverse portfolio of trials for patients with breast, gastrointestinal, genitourinary, respiratory, central nervous system, hematological malignancies, and selected rare tumors. Particular strengths of the Alliance include the long-standing tradition of collaborative research of the legacy members, including many who have participated in cooperative group research since its inception in 1955. The Mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by: – Conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; – Furthering our understanding of the biological basis of the cancer process and its treatment; from discovery, to validation, to clinical practice; – Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.

项目摘要 该联盟是一个经验丰富的多机构癌症临床试验组，已重组 对IOM共识报告和NCI合作集团重组指令的响应。联盟 提供全面且高效的临床试验基础设施，与经验丰富的合作者访问 在肿瘤学临床试验研究的所有学科中 胃肠道，泌尿生殖器，呼吸系统，中枢神经系统，血液学恶性肿瘤和选定 稀有肿瘤。联盟的特殊优势包括合作研究的长期传统 传统成员，包括自成立以来参加合作小组研究的许多人 1955年。 肿瘤学临床试验联盟的使命是通过以下方式减少癌症的影响： - 进行高质量的多学科控制，预防和治疗试验 综合研究网络； - 进一步了解我们对癌症过程及其治疗的生物学基础的理解；从 发现，验证，临床实践； - 为创新的临床和翻译研究提供科学和运营基础设施 学术和社区环境。